Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
50.2M
-
Shares change
-
+2.49M
-
Total reported value, excl. options
-
$434M
-
Value change
-
+$22.6M
-
Put/Call ratio
-
0.23
-
Number of buys
-
61
-
Number of sells
-
-42
-
Price
-
$8.65
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q2 2019
146 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q2 2019.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.2M shares
of 157M outstanding shares and own 31.94% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (6.88M shares), MILLENNIUM MANAGEMENT LLC (5.36M shares), BlackRock Inc. (5.3M shares), STATE STREET CORP (5.23M shares), VANGUARD GROUP INC (4.04M shares), BRIDGER MANAGEMENT, LLC (3.41M shares), FMR LLC (2.03M shares), Sofinnova Investments, Inc. (1.26M shares), Opaleye Management Inc. (1.15M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.03M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.